Literature DB >> 31008808

Hepatocellular carcinoma in the noncirrhotic liver: a literature review.

Yanan Zhang1, Chunguang Wang2, Hongqin Xu1, Peng Xiao1, Yanhang Gao1.   

Abstract

Development of hepatocellular carcinoma (HCC) is usually preceded by chronic liver injury and ongoing liver diseases. Liver cirrhosis reflects the outcome of long-term liver injury and is associated with an increased risk of developing HCC. However, HCC also arises in individuals without cirrhosis and bears several characteristics distinct from HCC in the cirrhotic liver. The molecular characteristics, prognosis, and surveillance of noncirrhotic HCC have not been adequately studied. In this review, we update readers and researchers in the field with the latest understanding of the epidemiology, etiology, clinical features, diagnosis, treatment strategies, prognosis, and surveillance of noncirrhotic HCC.

Entities:  

Year:  2019        PMID: 31008808     DOI: 10.1097/MEG.0000000000001419

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

1.  Clinical Importance of Incidentally Detected Hyperenhancing Liver Observations on Portal Venous Phase Computed Tomography in Patients Without Known Malignancy or Liver Disease.

Authors:  Michael T Corwin; Ryan T DiGeronimo; Shannon M Navarro; Ghaneh Fananapazir; Machelle Wilson; Thomas W Loehfelm
Journal:  J Comput Assist Tomogr       Date:  2021 Jul-Aug 01       Impact factor: 1.826

2.  Hepatocellular Carcinoma in Non-cirrhotic Liver Arises with a More Advanced Tumoral Appearance: A Single-Center Cohort Study.

Authors:  Coşkun Özer Demirtaş; Tuğba Tolu; Çaglayan Keklikkıran; Osman Cavit Özdoğan; Feyza Gündüz
Journal:  Turk J Gastroenterol       Date:  2021-08       Impact factor: 1.852

3.  The impact of liver fibrosis on microvascular invasion and prognosis of hepatocellular carcinoma with a solitary nodule: a Surveillance, Epidemiology, and End Results (SEER) database analysis.

Authors:  En Lin; Baojia Zou; Guifang Zeng; Chaonong Cai; Peiping Li; Jiafan Chen; Decheng Li; Baimeng Zhang; Jian Li
Journal:  Ann Transl Med       Date:  2021-08

4.  Prognostic and diagnostic value of SOX9 in cirrhotic and noncirrhotic hepatocellular carcinoma.

Authors:  Zhong-Ping Xu; Yan Liu; Zhen-Ru Wu; Jian-Ping Gong; Yun-Bing Wang
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.